title: Revascularization/Regeneration performed in immature molars: case reports.
abstract: These 3 case reports the outcome of revascularization treatment in necrotic immature molars. During treatment, a tri antibiotic mix was used to disinfect the pulp for 2 weeks. Then a blood clot was created in the canal, over which mineral trioxide aggregate was placed. After 24 months, the immature molars showed continuation of root development. The patients were asymptomatic, no sinus tracts were evident and apical periodontitis was resolved Results from these cases show that revascularization/regeneration using 3Mix-MP method could be effective for managing immature permanent molar teeth with pulpal necrosis.
authors.affiliation: Adnan Mendres University, Faculty of Dentistry, Department of Pediatric Dentistry, Aydin, Turkey. isilsaroglu@yahoo.com
authors.forename: I S
authors.initials: IS
authors.lastname: Sönmez
authors.forename: A
authors.initials: A
authors.lastname: Akbay Oba
authors.forename: M
authors.initials: M
authors.lastname: Erkmen Almaz
mesh_terms: D017607:Aluminum Compounds / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D056624:Apexification / Q000379:methods; D017610:Calcium Compounds / Q000627:therapeutic use; D002648:Child; D002939:Ciprofloxacin / Q000627:therapeutic use; D003738:Dental Cements / Q000627:therapeutic use; D003782:Dental Pulp / Q000187:drug effects; D003790:Dental Pulp Necrosis / Q000188:drug therapy / Q000628:therapy*; D003804:Dentin / Q000187:drug effects; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008911:Minocycline / Q000627:therapeutic use; D008963:Molar / Q000098:blood supply / Q000187:drug effects / Q000473:pathology*; D018919:Neovascularization, Physiologic / Q000502:physiology*; D010087:Oxides / Q000627:therapeutic use; D010482:Periapical Abscess / Q000188:drug therapy / Q000628:therapy; D011145:Polyvinyls / Q000627:therapeutic use; D012038:Regeneration / Q000502:physiology*; D012387:Root Canal Filling Materials / Q000627:therapeutic use; D018915:Root Canal Preparation / Q000379:methods; D017640:Silicates / Q000627:therapeutic use; D019227:Tooth Apex / Q000098:blood supply / Q000187:drug effects / Q000473:pathology*; D016896:Treatment Outcome; D015034:Zinc Oxide / Q000627:therapeutic use
chemical_list: C551230:3Mix ointment; D017607:Aluminum Compounds; D000900:Anti-Bacterial Agents; D017610:Calcium Compounds; D003738:Dental Cements; D004338:Drug Combinations; D010087:Oxides; D011145:Polyvinyls; D012387:Root Canal Filling Materials; D017640:Silicates; C086631:mineral trioxide aggregate; D008795:Metronidazole; D002939:Ciprofloxacin; C020873:Cavit G; D008911:Minocycline; D015034:Zinc Oxide